Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Epidemiology
Impact Of The Introduction Of Pneumococcal Conjugate Vaccine On Immunization Coverage Among Infants, Nancy D. Lin, Ken Kleinman, K Arnold Chan, Xian-Jie Yu, Eric K. France, Stanley Xu, Feifei Wei, John Mullooly, Jeanne Santoli, Tracey A. Lieu, Vaccine Safety Datalink Group
Impact Of The Introduction Of Pneumococcal Conjugate Vaccine On Immunization Coverage Among Infants, Nancy D. Lin, Ken Kleinman, K Arnold Chan, Xian-Jie Yu, Eric K. France, Stanley Xu, Feifei Wei, John Mullooly, Jeanne Santoli, Tracey A. Lieu, Vaccine Safety Datalink Group
Public Health Department Faculty Publication Series
Background
The introduction of pneumococcal conjugate vaccine (PCV) to the U.S. recommended childhood immunization schedule in the year 2000 added three injections to the number of vaccinations a child is expected to receive during the first year of life. Surveys have suggested that the addition of PCV has led some immunization providers to move other routine childhood vaccinations to later ages, which could increase the possibility of missing these vaccines. The purpose of this study was to evaluate whether introduction of PCV affected immunization coverage for recommended childhood vaccinations among 13-month olds in four large provider groups.
Methods
In this …
Group Versus Individual Academic Detailing To Improve The Use Of Antihypertensive Medications In Primary Care: A Cluster-Randomized Controlled Trial, Steven R. Simon, Sumit R. Majumdar, Lisa A. Prosser, Susanne Salem-Schatz, Cheryl Warner, Ken Kleinman, Irina Miroshnik, Stephen B. Soumerai
Group Versus Individual Academic Detailing To Improve The Use Of Antihypertensive Medications In Primary Care: A Cluster-Randomized Controlled Trial, Steven R. Simon, Sumit R. Majumdar, Lisa A. Prosser, Susanne Salem-Schatz, Cheryl Warner, Ken Kleinman, Irina Miroshnik, Stephen B. Soumerai
Public Health Department Faculty Publication Series
Purpose
To compare group versus individual academic detailing to increase diuretic or β-blocker use in hypertension.
Methods
We conducted a cluster-randomized controlled trial in a large health maintenance organization. Subjects (N=9820) were patients with newly treated hypertension in the year preceding the intervention (N=3692), the 9 months following the intervention (N=3556), and the second year following intervention (N=2572). We randomly allocated 3 practice sites to group detailing (N=227 prescribers), 3 to individual detailing (N=235 prescribers), and 3 to usual care (N=319 prescribers). Individual detailing entailed a physician-educator meeting individually with clinicians to address barriers to prescribing guideline-recommended medications. The group …